画像誘導ナビゲーション市場は、2025年の25億4,560万ドルから2030年までに39億1,250万ドルに成長し、予測期間中に9.0%のCAGRで成長すると予想されます。画像誘導ナビゲーション市場における著名なプレーヤーは、Medtronic(米国)、Brainlab AG(ドイツ)、Stryker(米国)、B. Braun SE(ドイツ)、Koninklijke Philips N.V.(オランダ)、GE Healthcare(米国)、オリンパス株式会社(日本)、Smith & Nephew(英国)、Johnson & Johnson Services, Inc.(米国)、Globus Medical(英国)です。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources of secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key objectives of primary research
2.1.2.2 Key data from primary sources
2.1.2.3 Insights from primary experts
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE SHARE ANALYSIS (SUPPLY SIDE)
2.2.2 TOP-DOWN APPROACH
2.2.3 DEMAND-SIDE APPROACH
2.2.4 VOLUME DATA ANALYSIS
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 IMAGE-GUIDED NAVIGATION MARKET OVERVIEW
4.2 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT AND COUNTRY, 2024
4.3 IMAGE-GUIDED NAVIGATION MARKET: REGIONAL MIX
4.4 IMAGE-GUIDED NAVIGATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
4.5 IMAGE-GUIDED NAVIGATION MARKET: EMERGING VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing adoption of minimally invasive surgical procedures
5.2.1.2 Rising uptake of robotics in surgeries
5.2.1.3 High government investments, funds, and grants for minimally invasive surgeries
5.2.1.4 Increasing applications of image-guided navigation across medical specialties
5.2.2 RESTRAINTS
5.2.2.1 High cost of image-guided navigation systems in surgical and interventional procedures
5.2.2.2 Lack of system accuracy and reliability
5.2.3 OPPORTUNITIES
5.2.3.1 Rising investments in healthcare AI and big data analytics
5.2.3.2 Increasing partnerships and collaborations among large industry players
5.2.4 CHALLENGES
5.2.4.1 Rising number of product recalls
5.2.4.2 Limited adoption of image-guided navigation surgeries in emerging economies
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 AI-based image analysis
5.3.1.2 Robot-assisted navigation
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 Patient-specific 3D modelling
5.3.2.2 Cloud-based and remote navigation
5.4 PORTER'S FIVE FORCES ANALYSIS
5.4.1 INTENSITY OF COMPETITIVE RIVALRY
5.4.2 BARGAINING POWER OF BUYERS
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 THREAT OF SUBSTITUTES
5.4.5 THREAT OF NEW ENTRANTS
5.5 KEY STAKEHOLDERS & BUYING CRITERIA
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.5.2 KEY BUYING CRITERIA
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY LANDSCAPE
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.2 Europe
5.6.1.3 Asia Pacific
5.6.1.3.1 Japan
5.6.1.3.2 China
5.6.1.3.3 India
5.6.1.4 Latin America
5.6.1.4.1 Brazil
5.6.1.5 Middle East & Africa
5.6.1.5.1 UAE
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 PATENT ANALYSIS
5.7.1 INSIGHTS ON PATENT PUBLICATION TRENDS (TOP APPLICANTS/JURISDICTION)
5.7.2 LIST OF MAJOR PATENTS, 2023-2025
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA FOR HS CODE 901820, 2020-2024
5.8.2 EXPORT DATA FOR HS CODE 901820, 2020-2024
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS, BY KEY PLAYER, 2022-2024
5.9.2 AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS, BY REGION, 2022-2024
5.10 KEY CONFERENCES & EVENTS, 2025-2026
5.11 UNMET NEEDS/END-USER EXPECTATIONS
5.12 VALUE CHAIN ANALYSIS
5.13 SUPPLY CHAIN ANALYSIS
5.14 ECOSYSTEM ANALYSIS
5.15 CASE STUDY ANALYSIS
5.15.1 BRAINLAB'S SMART NAVIGATION SYSTEM TO IMPROVE BRAIN TUMOR SURGERY
5.15.2 ZIMMER BIOMET'S ROBOTIC NAVIGATION TO ASSIST MINIMALLY INVASIVE JOINT REPLACEMENT SURGERIES
5.15.3 MEDTRONIC'S PRECISION NAVIGATION SYSTEM TO CONDUCT ADVANCED SPINE SURGERIES
5.16 ADJACENT MARKET ANALYSIS
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI/GEN AI ON IMAGE-GUIDED NAVIGATION MARKET
5.20 IMPACT OF 2025 US TARIFF ON IMAGE-GUIDED NAVIGATION MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON COUNTRY/REGION
5.20.4.1 North America
5.20.4.1.1 US
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 IMPACT ON END-USE INDUSTRIES
5.20.5.1 Hospitals
5.20.5.2 Ambulatory surgery centers
5.20.5.3 Diagnostic imaging centers
6 IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 WORKSTATIONS & SOFTWARE
6.2.1 DEMAND FOR ADVANCED SURGICAL PLANNING TOOLS AND REAL-TIME INTRAOPERATIVE NAVIGATION SYSTEMS TO DRIVE MARKET
6.3 NAVIGATORS
6.3.1 PREVALENCE OF COMPLEX MEDICAL CONDITIONS REQUIRING PRECISE SURGICAL INTERVENTIONS TO AUGMENT MARKET GROWTH
6.4 CONSUMABLES
6.4.1 INCREASING POPULARITY OF MINIMALLY INVASIVE SURGERIES TO BOOST DEMAND FOR CONSUMABLES
7 IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING
7.1 INTRODUCTION
7.2 INTERVENTIONAL RADIOLOGY SUITE
7.2.1 GROWING INTEGRATION OF HYBRID OPERATING ROOMS WITH ADVANCED IMAGING CAPABILITIES TO SUPPORT MARKET GROWTH
7.3 SURGICAL
7.3.1 SURGICAL NAVIGATION SYSTEMS TO MINIMIZE TISSUE DAMAGE AND ENABLE MORE TARGETED INTERVENTIONS
7.4 OTHER CARE SETTINGS
8 IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA
8.1 INTRODUCTION
8.2 ONCOLOGY
8.2.1 INCREASING INCIDENCE OF CANCER TO DRIVE MARKET
8.3 NEUROLOGY
8.3.1 NEED FOR HIGH PRECISION IN BRAIN AND SPINAL SURGERIES TO SUPPORT MARKET GROWTH
8.4 ENT
8.4.1 INCREASING INCIDENCE OF COMPLEX ENT-RELATED INJURIES AND DISEASES TO FAVOR MARKET GROWTH
8.5 PULMONARY
8.5.1 HIGH BURDEN OF LUNG CANCER TO SPUR MARKET GROWTH
8.6 GASTROENTEROLOGY
8.6.1 INCREASED PREVALENCE OF COLORECTAL CANCER TO AUGMENT MARKET GROWTH
8.7 MUSCULOSKELETAL
8.7.1 RISING MUSCULOSKELETAL SURGICAL VOLUME TO FAVOR MARKET GROWTH
8.8 DENTAL
8.8.1 IMAGE-GUIDED DENTAL NAVIGATION SYSTEMS TO FACILITATE MINIMALLY-INVASIVE PROCEDURES AND ENHANCE PATIENT RECOVERY
8.9 CARDIOVASCULAR
8.9.1 HIGH PREVALENCE OF CARDIOVASCULAR DISEASES TO AID MARKET GROWTH
8.10 OTHER THERAPY AREAS
9 IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION
9.1 INTRODUCTION
9.2 OPTICAL NAVIGATION
9.2.1 HIGH PRECISION AND SEAMLESS INTEGRATION WITH IMAGING MODALITIES TO AID ADOPTION IN SURGICAL APPLICATIONS
9.3 ELECTROMAGNETIC NAVIGATION
9.3.1 TECHNOLOGICAL ADVANCEMENTS AND AVAILABILITY OF HIGH-PRECISION GUIDANCE TO PROPEL MARKET GROWTH
9.4 ROBOTIC-ASSISTED TRACKING AND AUGMENTED REALITY & MIXED REALITY NAVIGATION
9.4.1 GROWING REQUIREMENT FOR ADVANCED VISUALIZATION AND PRECISION IN COMPLEX SURGERIES TO DRIVE MARKET
10 IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE
10.1 INTRODUCTION
10.2 CT-BASED REFERENCE
10.2.1 WIDESPREAD CLINICAL USE AND DIAGNOSTIC ACCURACY OF CT SCANS TO PROPEL MARKET GROWTH
10.3 FLUOROSCOPY-BASED REFERENCE
10.3.1 ADVANCEMENTS IN FLUOROSCOPY TECHNOLOGY FOR COMPLEX SURGERIES TO AUGMENT MARKET GROWTH
10.4 MRI-BASED REFERENCE
10.4.1 SUPERIOR IMAGING CAPABILITIES TO ACCELERATE MARKET GROWTH
10.5 ULTRASOUND-BASED REFERENCE
10.5.1 TECHNOLOGICAL ADVANCEMENTS TO FUEL UPTAKE OF ULTRASOUND-BASED REFERENCE IN POINT-OF-CARE APPLICATIONS
10.6 OTHER REFERENCE MODALITY TYPES
11 IMAGE-GUIDED NAVIGATION MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOSPITALS
11.2.1 BETTER RESOURCE AND COST MANAGEMENT TO FAVOR MARKET GROWTH
11.3 AMBULATORY SURGERY CENTERS
11.3.1 COST-EFFECTIVENESS AND IMPROVED PATIENT CONVENIENCE TO FAVOR MARKET GROWTH
11.4 DIAGNOSTIC IMAGING CENTERS
11.4.1 DIAGNOSTIC IMAGING CENTERS TO INTEGRATE IMAGE-GUIDED NAVIGATION SYSTEMS FOR IMPROVED PROCEDURAL OUTCOMES
12 IMAGE-GUIDED NAVIGATION MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 US to dominate North American image-guided navigation market during forecast period
12.2.3 CANADA
12.2.3.1 High government investments in digital research infrastructure to propel market growth
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Strong healthcare infrastructure and demand for advanced surgical technologies to augment market growth
12.3.3 UK
12.3.3.1 High burden of complex diseases and well-developed public healthcare system to fuel market growth
12.3.4 FRANCE
12.3.4.1 Increased demand for minimally invasive surgeries and favorable government investments in digital health to aid market growth
12.3.5 ITALY
12.3.5.1 Strong network of public and private hospitals and high prevalence of complex diseases to propel market growth
12.3.6 SPAIN
12.3.6.1 Advancements in healthcare infrastructure to boost market growth
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Large patient population and favorable government initiatives to fuel adoption during surgeries
12.4.3 JAPAN
12.4.3.1 High geriatric population and universal reimbursement policy for standardized healthcare services to drive market
12.4.4 INDIA
12.4.4.1 Availability of skilled medical professionals to augment market growth
12.4.5 SOUTH KOREA
12.4.5.1 Advanced healthcare infrastructure and increased popularity of robot-assisted surgeries to fuel market growth
12.4.6 AUSTRALIA
12.4.6.1 Rising burden of neurological and spinal disorders to fuel uptake of image-guided navigation products
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Increased government healthcare budget and favorable regulatory policies to support market growth
12.5.3 MEXICO
12.5.3.1 Nearshoring of medical device manufacturing to propel market growth
12.5.4 ARGENTINA
12.5.4.1 High government healthcare investments and increased prevalence of chronic diseases to drive market
12.5.5 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 GCC COUNTRIES
12.6.2.1 Increased government investments in medical sector to spur market growth
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IMAGE-GUIDED NAVIGATION MARKET
13.3 REVENUE ANALYSIS, 2020-2024
13.4 MARKET SHARE ANALYSIS, 2024
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Product footprint
13.5.5.4 Care setting footprint
13.5.5.5 Therapy area footprint
13.5.5.6 Type of navigation footprint
13.5.5.7 Reference modality type footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/ SMES, 2024
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
13.6.5.1 Detailed list of key startups/SME players
13.6.5.2 Competitive benchmarking of startups/SME players
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 R&D ASSESSMENT OF KEY PLAYERS
13.10 COMPETITIVE SCENARIO
13.10.1 PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
13.10.2 DEALS
13.10.3 EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 MEDTRONIC
14.1.1.1 Business overview
14.1.1.2 Products/Services/Solutions offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches
14.1.1.3.2 Deals
14.1.1.3.3 Expansions
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 BRAINLAB AG
14.1.2.1 Business overview
14.1.2.2 Products/Services/Solutions offered
14.1.2.3 Recent developments
14.1.2.3.1 Product approvals
14.1.2.3.2 Deals
14.1.2.4 MnM view
14.1.2.4.1 Key strengths
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 STRYKER
14.1.3.1 Business overview
14.1.3.2 Products/Services/Solutions offered
14.1.3.3 Recent developments
14.1.3.3.1 Product approvals
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 B. BRAUN SE
14.1.4.1 Business overview
14.1.4.2 Products/Services/Solutions offered
14.1.4.3 Recent developments
14.1.4.3.1 Deals
14.1.4.4 MnM view
14.1.4.4.1 Right to win
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 KONINKLIJKE PHILIPS N.V.
14.1.5.1 Business overview
14.1.5.2 Products/Services/Solutions offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.4 MnM view
14.1.5.4.1 Key strengths
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 GE HEALTHCARE
14.1.6.1 Business overview
14.1.6.2 Products/Services/Solutions offered
14.1.6.3 Recent developments
14.1.6.3.1 Product approvals
14.1.6.3.2 Deals
14.1.7 OLYMPUS CORPORATION
14.1.7.1 Business overview
14.1.7.2 Products/Services/Solutions offered
14.1.7.3 Recent developments
14.1.7.3.1 Deals
14.1.8 SMITH+NEPHEW
14.1.8.1 Business overview
14.1.8.2 Products/Services/Solutions offered
14.1.8.3 Recent development
14.1.8.3.1 Deals
14.1.9 JOHNSON & JOHNSON SERVICES, INC.
14.1.9.1 Business overview
14.1.9.2 Products/Services/Solutions offered
14.1.9.3 Recent development
14.1.9.3.1 Deals
14.1.10 GLOBUS MEDICAL (NUVASIVE)
14.1.10.1 Business overview
14.1.10.2 Products/Services/Solutions offered
14.1.10.3 Recent development
14.1.10.3.1 Deals
14.1.11 STEREOTAXIS, INC.
14.1.11.1 Business overview
14.1.11.2 Products/Services/Solutions offered
14.1.11.3 Recent developments
14.1.11.3.1 Product approvals
14.1.11.3.2 Deals
14.1.12 ORTHOFIX MEDICAL INC.
14.1.12.1 Business overview
14.1.12.2 Products/Services/Solutions offered
14.1.12.3 Recent developments
14.1.12.3.1 Deals
14.1.13 INTEGRA LIFESCIENCES CORPORATION
14.1.13.1 Business overview
14.1.13.2 Products/Services/Solutions offered
14.1.13.3 Recent developments
14.1.13.3.1 Deals
14.1.14 ZIMMER BIOMET
14.1.14.1 Business overview
14.1.14.2 Products/Services/Solutions offered
14.1.14.3 Recent developments
14.1.14.3.1 Deals
14.1.15 INTUITIVE SURGICAL
14.1.15.1 Business overview
14.1.15.2 Products/Services/Solutions offered
14.1.15.3 Recent developments
14.1.15.3.1 Other developments
14.2 OTHER PLAYERS
14.2.1 KARL STORZ
14.2.2 FIAGON GMBH
14.2.3 ZETA SURGICAL INC.
14.2.4 BRAIN NAVI BIOTECHNOLOGY CO., LTD.
14.2.5 IMAGE NAVIGATION, LTD.
14.2.6 HAPPY RELIABLE SURGERIES PVT. LTD.
14.2.7 RXOOM HEALTHCARE PVT. LTD.
14.2.8 CLARONAV
14.2.9 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
14.2.10 ZIEHM IMAGING GMBH
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
